09 July 2012 | General, CMST
Developing new therapies for cancer, infectious and virus-related diseases

COST Action CM1105 ‘Functional metal complexes that bind to biomolecules’ partners with a symposium on platinum coordination compounds and invites representatives from other COST Actions to submit an abstract for the conference.

The activities of the COST Action CM1105 are interlinked with the programme of the International Symposium on ‘Platinum Coordination Compounds in Cancer Chemotherapy, Stem Cells, DNA repair mechanisms, DNA-damaging agents’ (XI ISPCC ) to be held in Verona, Italy, in October 2012.

COST Action CM1105’s main objective is to develop and evaluate new metal-based compounds that exert their function as metallo-drugs – as research tools or as diagnostic tools – by binding to biomolecules. The scientific network focuses on understanding their modes of action with the ultimate aim to develop new therapies for cancer, infectious and virus-related diseases.

The topics addressed by this COST Action are linked to the programme proposed by the scientific committee of XI ISPCC. Several sessions at the symposium will be of high interest to COST Actions from the Domains of Chemistry and Molecular Sciences and Technologies (CMST), and Biomedicine and Molecular Biosciences (BMBS). Among these topics are 'New areas of clinical research with platinums, other metals, other DNA damaging agents', 'Optimizing clinical applications, with an emphasis on new targets' and 'New platinums and new formulations'.

COST Actions are cordially invited to submit an abstract for the conference.  

In addition, the symposium organisers grant COST Action CM1105 participants the opportunity to register for participation at a reduced fee.

For more information on this symposium, which involves the University of Verona, the New York Medical School, the European Society for Medical Oncology to name but a few, please visit the conference website.